{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:22:55Z","timestamp":1793748175536,"version":"4.6.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100016071","name":"Qingdao Municipal Bureau of Human Resource and Social Security","doi-asserted-by":"publisher","award":["QDBSH20250101023"],"award-info":[{"award-number":["QDBSH20250101023"]}],"id":[{"id":"10.13039\/100016071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015047","name":"Laoshan Laboratory","doi-asserted-by":"publisher","award":["8-01"],"award-info":[{"award-number":["8-01"]}],"id":[{"id":"10.13039\/501100015047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1706210"],"award-info":[{"award-number":["U1706210"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["42376116"],"award-info":[{"award-number":["42376116"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82504665"],"award-info":[{"award-number":["82504665"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["41322037"],"award-info":[{"award-number":["41322037"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010761","name":"Syngenta International","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010761","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ejmech.2026.118658","type":"journal-article","created":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T15:41:55Z","timestamp":1770565315000},"page":"118658","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Marine natural product-inspired 2-(3,4,5-trimethoxybenzoyl)quinazolin-4(3H)-one derivative CHNQD-01522: A novel anti-hepatocellular carcinoma agent targeting colchicine binding site of microtubule"],"prefix":"10.1016","volume":"307","author":[{"given":"Peng-Jie","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Qin","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Xiu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Ran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Yan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Cheng","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7230-188X","authenticated-orcid":false,"given":"Chang-Lun","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.118658_bib1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ejmech.2026.118658_bib2","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ejmech.2026.118658_bib3","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/med.21568","article-title":"Current advances of tubulin inhibitors as dual acting small molecules for cancer therapy","volume":"39","author":"Arnst","year":"2019","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2026.118658_bib4","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022608","article-title":"Microtubules and microtubule-associated proteins","volume":"10","author":"Goodson","year":"2018","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.ejmech.2026.118658_bib5","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1182\/blood-2019-122540","article-title":"Anticancer activity of a highly potent small molecule tubulin polymerization inhibitor","volume":"134","author":"Humbert","year":"2019","journal-title":"AB8939, Blood"},{"key":"10.1016\/j.ejmech.2026.118658_bib6","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1158\/1535-7163.MCT-09-0366","article-title":"Microtubule inhibitors: differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance","volume":"8","author":"Perez","year":"2009","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.ejmech.2026.118658_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.174802","article-title":"IMB5476, a novel microtubule inhibitor, induces mitotic catastrophe and overcomes multidrug resistance in tumors","volume":"919","author":"Zheng","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118658_bib8","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1002\/mog2.46","article-title":"Microtubule-targeting agents for cancer treatment: seven binding sites and three strategies","volume":"2","author":"Wang","year":"2023","journal-title":"MedComm-Oncology"},{"key":"10.1016\/j.ejmech.2026.118658_bib9","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/14728222.2024.2341630","article-title":"An update on the development on tubulin inhibitors for the treatment of solid tumors","volume":"28","author":"Yakkala","year":"2024","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.ejmech.2026.118658_bib10","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.2165\/11207520-000000000-00000","article-title":"Eribulin","volume":"71","author":"Perry","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2026.118658_bib11","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1001\/jama.1963.03700090061010","article-title":"Vincristine treatment of cancer in children","volume":"183","author":"Selawry","year":"1963","journal-title":"JAMA"},{"key":"10.1016\/j.ejmech.2026.118658_bib12","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1038\/sj.bjc.6601496","article-title":"The taxanes: toxicity and quality of life considerations in advanced ovarian cancer","volume":"89","author":"Guastalla","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejmech.2026.118658_bib13","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.bbrc.2016.09.128","article-title":"Mechanism of paclitaxel resistance in a human prostate cancer cell line, PC3-PR, and its sensitization by cabazitaxel","volume":"479","author":"Sobue","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2026.118658_bib14","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.neuroscience.2011.12.023","article-title":"Characterization of oxaliplatin-induced chronic painful peripheral neuropathy in the rat and comparison with the neuropathy induced by paclitaxel","volume":"203","author":"Xiao","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejmech.2026.118658_bib15","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.3390\/ijms18081733","article-title":"Taxol\u00ae: the first microtubule stabilizing agent","volume":"18","author":"Yang","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.118658_bib16","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0140-6736(85)90271-5","article-title":"Vincristine toxicity","volume":"326","author":"Dupuis","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2026.118658_bib17","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3892\/ijo.2023.5567","article-title":"Mechanism of multidrug resistance to chemotherapy mediated by P-glycoprotein","volume":"63","author":"Tian","year":"2023","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejmech.2026.118658_bib18","article-title":"Medicinal chemistry strategies to discover P-glycoprotein inhibitors: an update, drug resist","volume":"49","author":"Dong","year":"2020","journal-title":"Update"},{"key":"10.1016\/j.ejmech.2026.118658_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108488","article-title":"Strategies to overcome cancer multidrug resistance (MDR) through targeting P-glycoprotein (ABCB1): an updated review","volume":"249","author":"Dong","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2026.118658_bib20","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/s41568-023-00612-3","article-title":"Advances in the structure, mechanism and targeting of chemoresistance-linked ABC transporters","volume":"23","author":"Sajid","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2026.118658_bib21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/ph13010008","article-title":"Colchicine-binding site inhibitors from chemistry to clinic: a review","volume":"13","author":"McLoughlin","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2026.118658_bib22","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.drudis.2021.12.001","article-title":"Molecular interactions at the colchicine binding site in tubulin: an X-ray crystallography perspective","volume":"27","author":"Wang","year":"2022","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2026.118658_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113930","article-title":"Identification and optimization of biphenyl derivatives as novel tubulin inhibitors targeting colchicine-binding site overcoming multidrug resistance","volume":"228","author":"Cheng","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118658_bib24","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ejmech.2016.05.066","article-title":"Synthesis, anti-inflammatory, analgesic, COX-1\/2 inhibitory activities and molecular docking studies of substituted 2-mercapto-4(3H)-quinazolinones","volume":"121","author":"Abdel-Aziz","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118658_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117193","article-title":"Marine natural product-inspired discovery of novel BRD4 inhibitors with anti-inflammatory activity","volume":"284","author":"Chen","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118658_bib26","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02637-18","article-title":"The Quinazolinone allosteric inhibitor of PBP 2a synergizes with Piperacillin and tazobactam against methicillin-resistant Staphylococcus aureus","volume":"63","author":"Janardhanan","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.118658_bib27","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ejmech.2015.03.014","article-title":"Synthesis, crystal structure and biological evaluation of substituted quinazolinone benzoates as novel antituberculosis agents targeting acetohydroxyacid synthase","volume":"94","author":"Lu","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118658_bib28","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ejmech.2012.04.010","article-title":"Design, synthesis and antiviral activity of novel quinazolinones","volume":"53","author":"Wang","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118658_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104695","article-title":"Design, synthesis and molecular modeling of new quinazolin-4(3H)-one based VEGFR-2 kinase inhibitors for potential anticancer evaluation","volume":"109","author":"Abdallah","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.118658_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241311044","article-title":"Design, synthesis, and biological evaluation of novel quinazolin-4(3H)-one-based histone deacetylase 6 (HDAC6) inhibitors for anticancer activity","volume":"24","author":"Khetmalis","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.118658_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114915","article-title":"Natural quinazolinones: from a treasure house to promising anticancer leads","volume":"245","author":"Li","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118658_bib32","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/annonc\/mdf054","article-title":"Raltitrexed: current clinical status and future directions","volume":"13","author":"Van Cutsem","year":"2002","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ejmech.2026.118658_bib33","doi-asserted-by":"crossref","first-page":"41353","DOI":"10.1039\/D0RA06642G","article-title":"Recent advances in the pharmacological diversification of quinazoline\/quinazolinone hybrids","volume":"10","author":"Auti","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2026.118658_bib34","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3390\/biom15020210","article-title":"Quinazolinones as potential anticancer agents: synthesis and action mechanisms","volume":"15","author":"Deng","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejmech.2026.118658_bib35","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/13543776.2018.1432596","article-title":"Quinazoline and quinazolinone as important medicinal scaffolds: a comparative patent review (2011\u20132016), expert Opin","volume":"28","author":"Hameed","year":"2018","journal-title":"Ther. Pat."},{"key":"10.1016\/j.ejmech.2026.118658_bib36","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.3390\/molecules16064861","article-title":"Recent advances in the studies on luotonins","volume":"16","author":"Liang","year":"2011","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.118658_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113671","article-title":"Discovery of penipanoid C-inspired 2-(3,4,5-trimethoxybenzoyl)quinazolin-4(3H)-one derivatives as potential anticancer agents by inhibiting cell proliferation and inducing apoptosis in hepatocellular carcinoma cells","volume":"224","author":"Wang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118658_bib38","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/anie.201911158","article-title":"The cytotoxic natural product vioprolide a targets nucleolar protein 14, which is essential for ribosome biogenesis","volume":"59","author":"Kirsch","year":"2019","journal-title":"Angew. Chem., Int. Ed."},{"key":"10.1016\/j.ejmech.2026.118658_bib39","doi-asserted-by":"crossref","first-page":"6958","DOI":"10.3390\/molecules27206958","article-title":"Transcriptomics and proteomics characterizing the anticancer mechanisms of natural rebeccamycin analog loonamycin in breast cancer cells","volume":"27","author":"Sun","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.118658_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111833","article-title":"Application of omics- and multi-omics-based techniques for natural product target discovery","volume":"141","author":"Zhang","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2026.118658_bib41","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.chembiol.2023.02.003","article-title":"Ainsliadimer A induces ROS-mediated apoptosis in colorectal cancer cells via directly targeting peroxiredoxin 1 and 2","volume":"30","author":"Lv","year":"2023","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.118658_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.115203","article-title":"Ergosterol alleviates hepatic steatosis and insulin resistance via promoting fatty acid \u03b2-oxidation by activating mitochondrial ACSL1","volume":"44","author":"Zheng","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejmech.2026.118658_bib43","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1186\/s12885-025-13834-5","article-title":"Establishment of a novel mouse model of colorectal cancer by orthotopic transplantation","volume":"25","author":"Chen","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejmech.2026.118658_bib44","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/j.1349-7006.2006.00276.x","article-title":"Development of an orthotopic transplantation model in nude mice that simulates the clinical features of human lung cancer","volume":"97","author":"Kang","year":"2006","journal-title":"Cancer Sci."},{"key":"10.1016\/j.ejmech.2026.118658_bib45","doi-asserted-by":"crossref","first-page":"21615","DOI":"10.1021\/acs.jmedchem.5c01879","article-title":"Beyond bioisosteres: impact of replacing a benzene ring with sp3-rich three-dimensional saturated bridged bicyclic match pairs on biotransformation, metabolic stability, and other ADME profiles","volume":"68","author":"Surendran","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118658_bib46","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.2147\/DDDT.S379496","article-title":"Recent Updates on the development of Deuterium-containing drugs for the treatment of cancer","volume":"16","author":"Belete","year":"2022","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejmech.2026.118658_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118406","article-title":"Design, synthesis, and evaluation of mupirocin prodrugs restoring systemic efficacy against MRSA","volume":"303","author":"Gong","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118658_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202203838","article-title":"Enhancing circulation and tumor accumulation of carboplatin via an erythrocyte-anchored prodrug strategy","volume":"61","author":"Yao","year":"2022","journal-title":"Angew. Chem., Int. Ed."},{"key":"10.1016\/j.ejmech.2026.118658_bib49","doi-asserted-by":"crossref","first-page":"7263","DOI":"10.2147\/IJN.S212978","article-title":"RGDV-modified gemcitabine: a nano-medicine capable of prolonging half-life, overcoming resistance and eliminating bone marrow toxicity of gemcitabine","volume":"14","author":"Liu","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejmech.2026.118658_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2024.122505","article-title":"Drug delivery under cover of erythrocytes extends drug half-life: a thrombolytic targeting therapy utilizing microenvironment-responsive artificial polysaccharide microvesicles","volume":"343","author":"Shan","year":"2024","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ejmech.2026.118658_bib51","first-page":"502","article-title":"Discovery of a potential bladder cancer inhibitor CHNQD-01281 by regulating EGFR and promoting infiltration of cytotoxic T cells, mar","volume":"6","author":"Liu","year":"2024","journal-title":"Life Sci. Today"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426001030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426001030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T13:42:46Z","timestamp":1775482966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426001030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":51,"alternative-id":["S0223523426001030"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118658","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Marine natural product-inspired 2-(3,4,5-trimethoxybenzoyl)quinazolin-4(3H)-one derivative CHNQD-01522: A novel anti-hepatocellular carcinoma agent targeting colchicine binding site of microtubule","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118658","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118658"}}